Deep Apple Therapeutics
PrivateLast Round
Series A
Dec 14, 2023
Total Funding Raised
$52M
Company Overview
Deep Apple Therapeutics is a biotechnology company that develops small-molecule drugs for inflammatory, metabolic, and endocrine diseases using a proprietary discovery engine that integrates cryo-electron microscopy, deep learning, and virtual screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Apple Therapeutics Comparables
Compare Deep Apple Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Terray Therapeutics | 79% | |
| Kallyope | 76% | |
| Confo Therapeutics | 75% | |
Deep Apple Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 14, 2023 |
Deep Apple Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 14, 2023
$52M round completed.
Deep Apple Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Deep Apple Therapeutics's valuation, stock price, and market status.